The Aetna-Caremark integration means coverage policy changes often propagate quickly across both Aetna and other Caremark-administered plans, though employer-specific contracts can produce variation
(Medicaids patchwork of GLP-1 coverage means each state has its own rules, and in at least 5 states they were able to get connected to Medicaid ePA channels)
Approved globally, including in the U.S., Europe, and Canada, it mimics the glucagon-like peptide-1 (GLP-1) receptor agonists
What gets consumed is different
When Retatrutide activates these receptors, users experience reduced hunger, earlier feelings of fullness during meals, and decreased food cravings between meals
While both medications support blood sugar control and weight reduction, they work differently in the body, which can lead to varying results for different patients